Saxagliptin-13C3 |
|
| Synonyms: (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; BMS 477118; BMS 477118-11; Onglyza; | |
| Cat. No.: S12065 | CAS No.: 1246812-44-1/361442-04-8(unlabelled) |
| MDL.: | Formula: C1513C3H25N3O2 |
| F.W.318.39 | Purity: 99% |
| Storage: No Data Available | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 10mg | $14000.00 | Enter qty and click checkbox |
 
|
$14000.00 |
| Catalog Number： | S12065 | CAS No.: | 1246812-44-1/361442-04-8(unlabelled) | |
| MDL: | Formula: | C1513C3H25N3O2 | ||
| F.W.: | 318.39 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | No Data Available | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | No Data Available | Stability: | ||
| Storage: | No Data Available | Category: | Reference Standard | |
| Reference: | Feng, J., et al.: J. Med. Chem., 50, 2297 (2007),Rosenstock, J., et al.: Diabetes Obes. Metab., 10, 376 (2008), Thomas, L., et al.: J. Pharmacol. Exp. Ther., 325, 175 (2008), | |||
| Application: | Labelled Saxagliptin. It is a potent and selective reversible inhibitor of dipeptidyl peptidase-4, which is being developed for the treatment of type 2 diabetes. It is absorbed rapidly after oral administration and has a pharmacokinetic profile compatible with once daily dosing. | |||
| Category: | Amines, Chiral Reagents, Heterocycles, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals | |||